1) Sanqi drop-pill prepared by solid dispersing technology
三七固体分散体滴丸
1.
Preparation craft and quality of Sanqi drop-pill prepared by solid dispersing technology;
三七固体分散体滴丸制备工艺及质量研究
2) Fufang Sanqi Pills
复方三七滴丸
1.
Effects of Fufang Sanqi Pills on Hemorheological Parameters, Platelet Aggregation and Thrombus Fromation in Experimental Animals;
复方三七滴丸对急性血瘀证大鼠血液流变学和家兔血小板聚集及血栓形成的影响
3) solid dispersion
固体分散
1.
METHODS Naproxen sodium and pseudoephedrine hydrochloride bilayed sustaineded-release tablets were prepared by the solid dispersion method and twice compressing method using HPMC as the matrix material.
方法采用固体分散技术,以羟丙甲纤维素为缓释骨架,二次压片制备萘普伪麻双层缓释片;并考察盐酸伪麻黄碱释放度的影响因素和释药特性。
2.
Methods The way of solid dispersion basic materials and non-water preparation was used to prepare effervescent tablets, and was compared with the traditional preparation procedures.
方法采用碱性固体分散-非水制粒工艺试制泡腾片,与改进的非水制粒工艺对比;对泡腾片处方采用正交设计的方法进行优化;并进行初步稳定性考察。
4) solid dispersion
固体分散体
1.
Preparation and dissolution characteristics of solid dispersion of ginsenoside Rg_3;
人参皂苷Rg_3固体分散体的制备与体外特性研究
2.
Preparation of Dragon’s blood solid dispersion and the study on their dissolutions;
龙血竭固体分散体的制备及其溶出效果的研究
3.
Study on preparation of nitrendipine solid dispersion using the solvent evaporation-deposition method;
溶剂蒸发-沉积法制备尼群地平固体分散体
5) solid dispersions
固体分散体
1.
Preparation and in vitro evaluation of nifedipine solid dispersions;
硝苯地平固体分散体的制备和溶出速率研究
2.
Preparation and dissolution properties of solid dispersions of puerarin with polyethylene glycol 6000;
葛根素-聚乙二醇6000固体分散体的制备及其溶解性能的研究
3.
Determination of 5F in the solid dispersions prepared by poloxamer and 5F extracted from Pteris semipinnata L;
半边旗有效成分5F-泊洛沙姆固体分散体中5F的含量测定
6) Solid dispersion system
固体分散体
1.
Quantitation of flavonoids in silymarin loaded solid dispersion system;
水飞蓟素固体分散体中总黄酮的测定
2.
To enhance the dissolution rate of ursolic acid(UA) from its preparation,solid dispersion systems of UA in PVP-K30 were prepared at various weight ratios by co-evaporation of drug and PVP-K30 ethanol solution.
采用聚乙烯吡咯烷酮(PVP-K30)作为载体,用溶剂法制备乌索酸(UA)固体分散体,以提高制剂中UA的溶出度;建立高效液相色谱(HPLC)法测定固体分散体的体外溶出度,并进行红外和紫外光谱分析,鉴别药物在载体中的存在状态。
补充资料：三七分
1.见"三七开"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条